Cargando…
Prenatal Screening for Chromosomal Abnormalities: Where do We Stand Today in Mediterranean Countries?
Over the last 4 decades the practice of prenatal screening has evolved from the second-trimester triple test to complex combinations of biophysical and biochemical testing for aneuploidy, testing of fetal DNA in the maternal circulation and development of screening tests for adverse pregnancy outcom...
Autor principal: | Rizos, Demetrios |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Communications and Publications Division (CPD) of the IFCC
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6295594/ https://www.ncbi.nlm.nih.gov/pubmed/30574037 |
Ejemplares similares
-
Precision diabetes: Where do we stand today?
por: Mohan, Viswanathan, et al.
Publicado: (2018) -
Oesophageal Adenocarcinomas: Where Do We Stand Today?
por: Karstens, Karl-Frederick, et al.
Publicado: (2020) -
The Journey for Lung Cancer Screening where we Stand Today
por: Wahla, Ali S., et al.
Publicado: (2022) -
The Ethics of Machine Learning in Medical Sciences: Where Do We Stand Today?
por: Basu, Treena, et al.
Publicado: (2020) -
A Review of Interleukin-1 in Heart Disease: Where Do We Stand Today?
por: Szekely, Yishay, et al.
Publicado: (2018)